Anzeige
Mehr »
Login
Freitag, 01.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Neuer Gold Rekord bei knapp 2.800 USD und Übernahme-Zirkus!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 01.12.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
01.12.23Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release156DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (OTC: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics...
► Artikel lesen
01.12.23SatixFy Receives NYSE American Notice of Non-compliance with Continued Listing Standards194REHOVOT, Israel--(BUSINESS WIRE)--SatixFy Communications Ltd. (the "Company" or "SatixFy") (NYSE AMERICAN: SATX), announced today that on November 30, 2023 the Company received written notice from...
► Artikel lesen
01.12.23NiSource Inc. Announces the Settlement Rate for the Purchase Contract Component of its 2021 Equity Units Offering175MERRILLVILLE, Ind.--(BUSINESS WIRE)--NiSource Inc. (NYSE: NI) ("NiSource") announced today the settlement rate of the purchase contracts that form part of its Series A Corporate Units (the "Corporate...
► Artikel lesen
01.12.23NYSE to Commence Delisting Proceedings Against CorEnergy Infrastructure Trust, Inc (CORR)278 NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange ("NYSE", the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities...
► Artikel lesen
01.12.23Eli Lilly and Company: Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Received at Least Two Lines of Therapy, Including a BTK Inhibitor and a B398The first and only non-covalent (reversible) BTK inhibitor, Jaypirca has been shown to extend the benefit of BTK inhibition In the BRUIN Phase 1/2 trial, adult patients with CLL/SLL who have received...
► Artikel lesen
01.12.23Volato Announces Closing of Business Combination with PROOF Acquisition Corp I; Secures Additional Equity Financing332ATLANTA & RESTON, Va.--(BUSINESS WIRE)--Volato, Inc., ("Volato") a leading private aviation company in the United States, and PROOF Acquisition Corp I (NYSE: PACI) ("PACI") today announced the...
► Artikel lesen
01.12.23Citizens Holding Company Announces Voluntary Delisting from the Nasdaq Global Market221PHILADELPHIA, Miss.--(BUSINESS WIRE)--Citizens Holding Company (the "Company") (NASDAQ:CIZN), the holding company for The Citizens Bank of Philadelphia (the "Bank"), today announced its voluntary...
► Artikel lesen
01.12.23HF Sinclair Corporation Completes Acquisition of Holly Energy Partners, L.P.240DALLAS--(BUSINESS WIRE)--HF Sinclair Corporation (NYSE: DINO) ("HF Sinclair") today announced the completion of the transactions contemplated by the previously announced Agreement and Plan of Merger...
► Artikel lesen
01.12.23IsoEnergy Ltd.: IsoEnergy Announces Approval of Arrangement by Consolidated Uranium Shareholders and Receipt of Final Order142SASKATOON, SK, Dec. 1, 2023 /CNW/ - IsoEnergy Ltd. ("IsoEnergy" or the "Company") (TSXV: ISO) (OTCQX: ISENF) is pleased to announce that the shareholders of Consolidated Uranium Inc. ("Consolidated...
► Artikel lesen
01.12.23Midsummer AB: Report from the extraordinary general meeting in Midsummer364NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF...
► Artikel lesen
01.12.23Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)506NEW YORK and SAN DIEGO, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated...
► Artikel lesen
01.12.23ZoomerMedia Limited Announces Financial Results for the Year Ended August 31, 2023311TORONTO, Dec. 01, 2023 (GLOBE NEWSWIRE) -- ZoomerMedia Limited (TSXV:ZUM) (the "Company"), the leader in serving the interests of the 17.2 million "Zoomers" aged 45-plus, and the generations that...
► Artikel lesen
01.12.23Freshworks Inc: Freshworks Announces Inducement Grant Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market434SAN MATEO, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Freshworks Inc. (NASDAQ: FRSH), a leading software company empowering businesses to delight their customers and employees, today announced that...
► Artikel lesen
01.12.23Aimei Health Technology Co., Ltd Announces Pricing of $60 Million Initial Public Offering484NEW YORK, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (NASDAQ: AFJKU, the "Company") announced today that it priced its initial public offering of 6,000,000 units at $10.00 per...
► Artikel lesen
01.12.23Fresh Tracks Therapeutics, Inc.: Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders412Meeting adjourned to December 15, 2023 at 10 a.m. MT Fresh Tracks encourages all stockholders of record on October 17, 2023 who have not yet voted to do so by 11:59 p.m. Eastern Time on December 14...
► Artikel lesen
01.12.23authID Inc.: authID Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)449Denver, Dec. 01, 2023 (GLOBE NEWSWIRE) -- authID Inc. (Nasdaq: AUID), a leading provider of secure identity verification and authentication solutions, today announced the grant of non-qualified options...
► Artikel lesen
01.12.23FLJ Group Limited Announces Plan to Implement ADS Ratio Change454SHANGHAI, China, Dec. 01, 2023 (GLOBE NEWSWIRE) -- FLJ Group Limited (NASDAQ: FLJ) (the "Company") today announced that it plans to change the ratio of the American depositary shares ("ADSs") representing...
► Artikel lesen
01.12.23Titan Medical Inc.: Titan Medical Announces Benchmark Electronics, Inc. Purported to Terminate Agreement478TORONTO, Ontario, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD; OTC: TMDIF), announced today that Benchmark Electronics, Inc., the company engaged by Titan...
► Artikel lesen
01.12.23Axogen, Inc.: Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)268ALACHUA and TAMPA, Fla., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...
► Artikel lesen
01.12.23Seaport Global Acquisition II Corp.: Seaport Global Acquisition II Corp Announces Final Value for Redemption of Public Shares287NEW YORK, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Seaport Global Acquisition II Corp. (Nasdaq: SGII) (the "Company"), a special purpose acquisition company, today announced the final per share redemption...
► Artikel lesen
Seite:  Weiter >>